EN
HI

ZENITH DRUGS Share price

ZENITHDRUG

HealthcareSmall

81.9

2.40 (3.02%)
NSE
BSE
Last updated on 2 May, 2025 | 12:10 IST
BUYSELL
Today's High

78.50

Today's Low

81.95

52 Week Low

154.40

52 Week High

154.40

The current prices are delayed, login to your account for live prices

Zenith Drugs Chart

ZENITH DRUGS Share Key Metrics

Volume
8800.00
Market Cap
136.33 CR
LTQ@LTP
800@81.90
ATP
80.46
Var Margin
10000
Circuit Range
75.55-83.45
Delivery %
100
Value
7.08 L
ASM/GSM
No
Market Lot
800

ZENITH DRUGS Futures & Options

Data Not Found

ZENITH DRUGS Corporate Actions

DateAgenda
No Data Found
DateEvent TypeAgenda
No Data Found

ZENITH DRUGS News

No Data Found

About ZENITH DRUGS

NSE : 22806  
BSE : 211179  
ISIN : INE0QWN01013  

Our Company was originally incorporated on November 15 2000 as a Private Limited Company in the name of “Zenith Drugs Private Limited” under the provisions of the Companies Act 1956 with the Registrar of Companies Madhya Pradesh Gwalior. Subsequently pursuant to a Special Resolution of our Shareholders passed in the Extra-Ordinary General Meeting held on September 05 2023 our Company was converted from a Private Limited Company to Public Limited Company and consequently the name of our Company was changed to ‘Zenith Drugs Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on September 13 2023 by the Registrar of Companies Gwalior.MAJOR EVENTS AND MILESTONES:2000-Incorporation of the Company.2001-Started as a manufacturing house for oral and external formulations.2004-Shifted to a Schedule M GMP compliant unit.-Started the production of two lines which are liquid orals and ointments.2007-Started manufacturing ORS Powder2016-Received WHO GMP certification2019-Turnover crossed 50 Crores.2020-Turnover crossed 75 Crores.2021-Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification-Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority-Our Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of ? 170.04 Lakhs2022-The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.2023-Turnover crossed 100 Crores.-Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.-Conversion of our Company from Private Limited Company to Public Limited Company.

ZENITH DRUGS Management

NamePosition
Mr. Sandeep Bhardwaj Managing Director
Mr. Ranjana Sureshkumar Sehgal Independent Director
Mr. Deendayal Kumawat Independent Director
Mr. Anil Malik Non Executive Director
Mr. Bhupesh Soni Director
Read More

ZENITH DRUGS FAQs

The Buying Price of ZENITH DRUGS share is 81.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy ZENITH DRUGS share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of ZENITH DRUGS shares is 14.72. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio ZENITH DRUGS shares is 2.26. Useful to assess the stock's value relative to its book value.

To assess ZENITH DRUGS’s valuation compare Sector P/E, P/B which are 34.04 & 4.81 with sector averages, along with growth rates and financial metrics.

The Market Cap of ZENITH DRUGS is 136.33 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of ZENITH DRUGS share price is 154.40 & 47.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.